You are here: Home » Current Affairs » Coronavirus » News
Business Standard

Serum Institute puts India trials of AstraZeneca's Covid-19 vaccine on hold

Serum Institute of India has put trials of AstraZeneca's Covid-19 vaccine candidate on hold until the British drugmaker restarts the trials, Serum said

Topics
Serum Institute of India | AstraZeneca | Coronavirus

Reuters  |  MUMBAI 

Coronavirus, vaccine, covid, drugs, Sepsivac, clinical trials

MUMBAI (Reuters) - has put trials of AstraZeneca's COVID-19 vaccine candidate on hold until the British drugmaker restarts the trials, Serum said on Thursday.

"We are reviewing the situation and pausing India trials," Serum said in a brief statement.

said on Tuesday it had paused trials of its experimental vaccine because of an unexplained illness in a study participant, but its partner Serum had at the time said its trials in India were still ongoing.

 

(Reporting by Euan Rocha in Mumbai; Additional reporting by Sachin Ravikumar in Bengaluru; Editing by Shounak Dasgupta)

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

First Published: Thu, September 10 2020. 15:45 IST
RECOMMENDED FOR YOU